Treatment for horses may lead to therapy for type of blindness
Picture a horse running across an open field, the wind blowing his mane, his hooves stamping into the grassy knoll, eyes on ...
Roivant Sciences reports Q3 EPS (22c), consensus (24c)
Reports Q3 revenue $9.02M, consensus $4.75M. “Roivant has broadened our clinical pipeline with the newly announced trial of brepocitinib in ...
Healio1d
Q&A: Congress on Controversies in Ophthalmology delves into current ophthalmic debates
The Congress on Controversies in Ophthalmology will be held April 4-5 in Seville, Spain.As the name implies, the unique ...
Could Fire Ants Be Linked to This Mysterious Eye Condition in Dogs and Cats?
A new study identifies Florida spot keratopathy (FSK) as a stable, benign eye condition in pets and suggests a possible link ...
The American Journal of Managed Care3d
Enhanced Monofocal Lenses May Provide Alternative in Glaucoma Treatment
Patients with varying stages of glaucoma saw no significant difference in outcomes between standard and enhanced monofocal ...
Pulsesight Therapeutics Announces First Close Of Its Series A Financing To Fund Clinical Development Of PST-611 In Dry AMD
PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...
Kiora Receives Approval to Initiate KLARITY, a Phase 2 Clinical Trial of KIO-104 for the Treatment of Retinal Macular Edema
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it received regulatory approval to ...
Active Biotech AB: Active Biotech Year End Report 2024
EVENTS DURING THE FOURTH QUARTEREuropean Patent Office granted Active Biotech's patent application for eye drop formulation of laquinimod (October 23)Active Biotech's clinical trial of tasquinimod in ...
ANI Pharmaceuticals: More Than Just A Generics Company
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...
Daily Monitor5d
Retired teacher Musisi wishes to return to work after 40 years of service
George Musisi,73, popularly known as Teacher Musisi by his former students and residents of Nyamitanga Hill in Mbarara City, ...
Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives $5.33 Consensus PT from Analysts
Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) has received an average recommendation of “Buy” from the six research firms that are currently covering the company, Ratings reports. Six ...